NIH researchers identified brain connections associated with ADHD in youth
On Mar. 13, 2024, researchers at the National Institutes of Health (NIH) announced they had discovered that symptoms…
On Mar. 13, 2024, researchers at the National Institutes of Health (NIH) announced they had discovered that symptoms…
On Feb. 24, 2024, C2N Diagnostics (C2N) announced the medical device registration from the United Kingdom’s Medicines and…
On Feb. 23, 2024, the California Institute for Regenerative Medicine (CIRM), the world’s largest institution dedicated to regenerative…
On Jan. 25, 2024, a study led by the University of Edinburgh, is the largest genetic study of…
On Jan. 25, 2024, dozens of noted scientists, philanthropists, and Washington University, state and local leaders celebrated the…
On Jan. 9, 2024, Biogen and Eisai announced that humanized anti- soluble aggregated amyloid-beta (Aβ) monoclonal antibody ‘LEQEMBI’…
On Dec. 14, 2023, the University of Michigan Center for Innovation (UMCI) in Detroit broke ground with high-energy…
On Dec. 14, 2023, the Department of Energy’s (DOE) Pacific Northwest National Laboratory (PNNL) announced that it had…
On Dec. 14, 2023, the University of Alberta announced that a study published in Nature sheds light on…
On Dec. 13, 2023, the Allen Institute and collaborators announced that after six years and 32 million cells,…
On Nov. 30, 2023, in a momentous landmark for medical research, UK Biobank announced that it had unveiled…
On Oct. 27, 2023, the California Institute for Regenerative Medicine (CIRM) awarded $42.1 million to fund various translational…
On Oct. 20, 2023, Pfizer announced that the U.S. Food and Drug Administration (FDA) had approved PENBRAYA (meningococcal…
On Oct. 12, 2023, the National Institute of health (NIH) announced that a group of international scientists had…
On Oct. 10, 2023, the University of Wisconsin-Madison researchers announced a new study published in the journal Neuron…
On Oct. 2, 2023, the California Institute for Regenerative Medicine (CIRM) announced its approval of a new program…
On Sept. 28, 2023, the U.S. Department of Agriculture’s (USDA) Animal and Plant Health Inspection Service (APHIS) announced…
On Sept. 15, 2023, a Northwestern Medicine study challenges a common belief in what triggers Parkinson’s disease. Degeneration…
On Aug. 28, 2023, in a study of 152 deceased athletes less than 30 years old who were…
On Aug. 23, 2023, a gene variant found almost exclusively in the genomes of people of African ancestry…
On Aug. 4, 2023, Biogen and Sage Therapeutics announced that the U.S. Food and Drug Administration (FDA) had…
On Jul. 28, 2023, in a first-of-its-kind clinical trial, bioelectronic medicine researchers, engineers and surgeons at Northwell Health’s…
On Jul. 19, 2023, a team of scientists from the Translational Genomics Research Institute (TGen), part of the…
On Jul. 6, 2023, Eisai and Biogen announced that the U.S. Food and Drug Administration (FDA) had approved the…
On Jun. 17, 2023, the Mississippi man known as “Case 1,” the first person to be diagnosed with…
Milestones in Parkinson’s illustrates advancements in the disease from James Parkinson’s essay on ‘shaking palsy’ to development of…
On May 11, 2023, the U.S. Food and Drug Administration (FDA) announced the supplemental approval of Otsuka Pharmaceutical…
On May 5, 2023, the National Institutes of Health reported that a study had identified features of Long…
On Apr. 13, 2023, in an enormous leap forward in the understanding of Parkinson’s disease (PD), researchers announced…
On Mar. 13, 2023, the U.S. Food and Drug Administration (FDA) announced that it had approved Acadia Pharmaceuticals’…